Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | In stock | $ 53.00 | |
50 mg | In stock | $ 61.00 | |
100 mg | In stock | $ 82.00 | |
200 mg | In stock | $ 118.00 | |
500 mg | In stock | $ 197.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Mutated EGFR-IN-1 (Osimertinib analog) is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant. |
In vitro | Mutated EGFR inhibitor acts as egfr modulators useful for treating cancer. |
Synonyms | Osimertinib analog |
Molecular Weight | 445.56 |
Formula | C25H31N7O |
CAS No. | 1421372-66-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: ≥ 75 mg/mL (168.33 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mutated EGFR-IN-1 1421372-66-8 Angiogenesis JAK/STAT signaling Tyrosine Kinase/Adaptors EGFR Mutated EGFR IN 1 Epidermal growth factor receptor inhibit ErbB-1 Osimertinib Inhibitor Osimertinib analog HER1 Mutated EGFRIN1 inhibitor